The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical and laboratory parameters associated with rapid progression in advanced NSCLC patients treated with second or third-line single agent immune checkpoint inhibitors (ICIs).
 
Megan Randall
No Relationships to Disclose
 
Philip D. Bonomi
Honoraria - Helsinn Therapeutics; Merck; pfizer
Consulting or Advisory Role - Helsinn Therapeutics; Merck; Pfizer
Research Funding - Helsinn Healthcare (Inst); Pfizer (Inst)
 
Sanjib Basu
No Relationships to Disclose
 
Jeffrey Allen Borgia
Patents, Royalties, Other Intellectual Property - Have invention for serological test for Covid-19 that is non-exclusively licensed to Tempus Labs.
 
Hita Moudgalya
No Relationships to Disclose
 
Revathi Kollipara
No Relationships to Disclose
 
Marta Batus
No Relationships to Disclose
 
Mary Jo J. Fidler
Honoraria - AstraZeneca; Genentech; Jazz Pharmaceuticals; Merck
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Daiichi Sankyo/Astra Zeneca; G1 Therapeutics; Genentech (I); Gilead Sciences; Lynx Group; Plexus; Rakuten Medical (Inst); Silverback Therapeutics
Speakers' Bureau - Genentech; Merck
Research Funding - alkermes (Inst); AstraZeneca (Inst); Biodesix; CytomX Therapeutics (Inst); Jounce Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer/EMD Serono; Rakuten Medical (Inst)